Cargando…
HPV Vaccination as Adjuvant to Conization in Women with Cervical Intraepithelial Neoplasia: A Study under Real-Life Conditions
Background: Recent studies have shown preliminary evidence that vaccination against human papillomavirus (HPV) could decrease the risk of persistent/recurrent HSIL in women treated for high-grade cervical intraepithelial lesion (HSIL). We aimed to determine the benefits of HPV vaccination in patient...
Autores principales: | del Pino, Marta, Martí, Cristina, Torras, Ines, Henere, Carla, Munmany, Meritxell, Marimon, Lorena, Saco, Adela, Torné, Aureli, Ordi, Jaume |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7349984/ https://www.ncbi.nlm.nih.gov/pubmed/32456136 http://dx.doi.org/10.3390/vaccines8020245 |
Ejemplares similares
-
HPV Vaccination in Women with Cervical Intraepithelial Neoplasia Undergoing Excisional Treatment: Insights into Unsolved Questions
por: Henere, Carla, et al.
Publicado: (2022) -
Natural History of Anal HPV Infection in Women Treated for Cervical Intraepithelial Neoplasia
por: del Pino, Marta, et al.
Publicado: (2023) -
Colposcopic Impression Has a Key Role in the Estimation of the Risk of HSIL/CIN3
por: del Pino, Marta, et al.
Publicado: (2021) -
Usefulness of E7 mRNA in HPV16-Positive Women to Predict the Risk of Progression to HSIL/CIN2+
por: Martí, Cristina, et al.
Publicado: (2021) -
CADM1, MAL, and miR124 Promoter Methylation as Biomarkers of Transforming Cervical Intrapithelial Lesions
por: del Pino, Marta, et al.
Publicado: (2019)